Sharon Worcester

Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.

Video

VIDEO: Sapien 3 TAVR bests surgery in intermediate-risk patients

Author:: Sharon Worcester

Publish date: April 6, 2016

CHICAGO – Transcatheter aortic valve replacement using Sapien 3 – the latest-generation valve – is associated with low mortality, stroke, and paravalv...

News

New ACC Consensus Guidance Addresses Nonstatin Therapies

Author:: Sharon Worcester

Publish date: April 3, 2016

Video

VIDEO: New ACC consensus guidance addresses nonstatin therapies

Author:: Sharon Worcester

Publish date: April 3, 2016

A new expert consensus decision pathway for the use of nonstatin therapies to lower cholesterol in high-risk patients released this week by the Americ...

News

Heart failure severity at AMI predicts long-term CV death risk

Author:: Sharon Worcester

Publish date: April 2, 2016

The severity of heart failure in the setting of acute myocardial infarction predicts long-term cardiovascular death risk, according to a post hoc anal...

News

FDA proposes ban on powdered gloves

Author:: Sharon Worcester

Publish date: March 21, 2016

The Food and Drug Administration has proposed a ban on most powdered gloves used during surgery and for patient examination, and on absorbable powder ...

News

FDA approves two new hemophilia therapies

Author:: Sharon Worcester

Publish date: March 17, 2016

The FDA approved Idelvion for hemophilia B therapy and Kovaltry to treat hemophilia A.

News

New CDC opioid guideline targets overprescribing for chronic pain

Author:: Sharon Worcester

Publish date: March 15, 2016

Nonopioid therapy is the preferred approach to manage chronic pain outside of active cancer, palliative, and end-of-life care, the CDC said.

News

Review: Use wider margins for DCIS surgery without radiotherapy

Author:: Sharon Worcester

Publish date: March 12, 2016

A margin width of at least 2 mm is optimal in women undergoing breast-conserving surgery and radiotherapy for ductal carcinoma in situ, according to t...

News

Breast cancer vaccines hold promise

Author:: Sharon Worcester

Publish date: March 11, 2016

Significant strides are being made in breast cancer immunology.

News

Stop using radiation therapy in older women, expert says

Author:: Sharon Worcester

Publish date: March 11, 2016

News

First U.S. uterus transplant raises questions about ethics, cost

Author:: Sharon Worcester

Publish date: March 7, 2016

The recipient of the first uterus transplant performed in the United States is recovering well and looking forward to the next phase of the research p...

News

Evidence builds for mesenchymal stem cell therapy in MS

Author:: Sharon Worcester

Publish date: March 7, 2016

Repeated intrathecal administration of autologous mesenchymal bone marrow–derived stromal stem cells for the treatment of multiple sclerosis was safe ...

News

Prenatal, postpartum education program improves breastfeeding duration

Author:: Sharon Worcester

Publish date: March 7, 2016

Targeted education to increase breastfeeding duration among women with gestational diabetes was feasible and effective in a randomized controlled life...

News

Prenatal, Postpartum Education Program Improves Breastfeeding Duration

Author:: Sharon Worcester

Publish date: March 7, 2016

Key clinical point: Targeted education is effective at increasing breastfeeding duration among women with gestational diabetes. Major finding: Wom...

News

BENEFIT 11: No new safety signals with interferon beta-1b

Author:: Sharon Worcester

Publish date: March 2, 2016

The long-term safety of interferon beta-1b for the treatment of multiple sclerosis is well established, and 11-year outcomes from the randomized, plac...